Vestibulectomy Surgical Techniques Comparison Study
Vestibulectomy: A Prospective Comparison of Two Surgical Techniques for the Treatment of Provoked Localized Vulvodynia (PVD)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Women's Health Research Unit Confidential Recruitment Line
- Phone Number: 503-494-3666
- Email: whru@ohsu.edu
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Recruiting
- Oregon Health and Science University
-
Contact:
- Women's Health Research Unit Confidential Recruitment Line
- Phone Number: 503-494-3666
- Email: whru@ohsu.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Reported provoked tenderness to the vestibule for at least 3 months in non-pregnant, estrogen-replete healthy subjects aged 18 years or over meeting Friedrich's criteria for PVD44-45 and supported by the ISSVD Terminology Consensus Definition45 for vulvar pain. Subjects who are >45years of age must have either have a maturation index52 of < 10% parabasal cells or willingness to participate in local estrogen replacement until achieving this same clinical result.
- Cotton swab Test30-31 mean verbal rating score of ≥4/10 in 4 of 6 defined points of the vestibule (2, 4, 6, 8, 10, 12 o'clock) and cotton swab test verbal score ≤ 2/10 for the labia majora and minora, intra labial sulcus, and perineum
- Ability to insert a regular Tampax® tampon
- Baseline Tampon Test verbal pain score ≥430
f. Phone and internet access e. Willingness to engage in pelvic floor physical therapy (PT)
Exclusion Criteria:
- Pregnancy
- Any other clinical reason for dyspareunia (endometriosis pain, chronic pelvic pain, vulvar dermatoses such as psoriasis, lichen sclerosus)
- Unable or unwilling to complete baseline assessments
- Prior vestibulectomy or hymen surgery
- Prior or current use of testosterone dosed for gender affirmation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Modified Vestibulectomy
|
This operation is performed using modified anesthesia care/deep sedation (MAC) for anesthesia.
The vestibule is removed to the boundary of Harts line.
The surgical flap for this procedure is the Hymen plus 1 cm of the vagina.
|
|
Active Comparator: Traditional Vestibulectomy
|
This operation is performed using an Laryngeal Mask Airway (LAM), (modified anesthesia care/deep sedation) for anesthesia.
The vestibule is removed 0.5 to 1 cm beyond the boundary of the Hart's line.
The Hymen plus 1 cm of the vagina is excised.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Tampon Test pain scores from baseline to 3 months
Time Frame: Baseline visit to 3 months after surgery
|
The change from baseline in pain measured by the Tampon Test at 3 months after surgery.
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine).
This test will occur at baseline and 3 months follow up.
|
Baseline visit to 3 months after surgery
|
|
Change in pain scores from baseline to 6 months
Time Frame: Baseline visit to 6 months after surgery
|
The change from baseline in pain measured by the Tampon Test at 6 months after surgery.
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine).
This test will occur at baseline and 6 months follow up.
|
Baseline visit to 6 months after surgery
|
|
Change in pain scores from baseline to 12 months
Time Frame: Baseline visit to 12 months after surgery
|
The change from baseline in pain measured by the Tampon Test at 12 months after surgery.
The tampon test is a validated tool used to measure (vulva) vestibular skin pain by having participants insert and remove a tampon.
Participants will be asked to rate their pain along a 100 mm Visual Analog Scale on a scale of 0 (No pain) to 10 (Pain as bad as you can imagine).
This test will occur at baseline and 12 months follow up.
|
Baseline visit to 12 months after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Catherine Leclair, MD, Oregon Health and Science University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OHSU IRB 24107
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.